Merrimack Pharmaceuticals
MACK
#7998
Rank
โ‚ฌ0.20 B
Marketcap
14,01ย โ‚ฌ
Share price
0.00%
Change (1 day)
2.09%
Change (1 year)

Earnings for Merrimack Pharmaceuticals (MACK)

Earnings in 2024 (TTM): -โ‚ฌ2.09 Million

According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚ฌ2.02 Million a decrease over its 2022 earnings that were of -โ‚ฌ2.02 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Merrimack Pharmaceuticals from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ2.09 Million3.58%
2023 -โ‚ฌ2.02 Million0.09%
2022 -โ‚ฌ2.02 Million-16.9%
2021 -โ‚ฌ2.43 Million-49.89%
2020 -โ‚ฌ4.84 Million-75.39%
2019 -โ‚ฌ19.65 Million-68.58%
2018 -โ‚ฌ62.54 Million-19.4%
2017 -โ‚ฌ77.59 Million-36.46%
2016 -โ‚ฌ0.13 Billion2.54%
2015 -โ‚ฌ0.12 Billion96.78%
2014 -โ‚ฌ60.52 Million-45.44%
2013 -โ‚ฌ0.12 Billion
2010 -โ‚ฌ43.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ7.35 B-351,673.26%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚ฌ26.9 Million 1,185.48%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.15 Billion 6,808.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.21 Billion 9,523.90%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ34.98 Million 1,571.40%๐Ÿ‡บ๐Ÿ‡ธ USA